U.S Department of Health & Human ServicesHHSNational Institutes of HealthNIHNCATSNCATSCTSA ProgramCTSA
CTSA CCOS

Coordination, Communication, and Operations Support

RegisterLog In
CTSA News
Need Help

CTSA News

CTSA News

Announcements

Date

April 9, 2024

Share this News Post

Barbara Slusher, M.D., M.A.S. Developing Treatment for Inflammatory Bowel Disease

There is a pill in the works that could treat a common and often severe set of inflammatory bowel diseases. 

  

The promising therapy and many more for a host of troubling and deadly diseases are now much more likely to make it to market because of a big bet by the majority owner of the Baltimore Ravens, Steve Bisciotti. 

  

The Stephen and Renee Bisciotti Foundation has put up $100 million for a new Baltimore-based nonprofit called Blackbird that will help shepherd five to 10 promising therapies a year from local university labs into local startup companies... 

 

Read the full article here.

Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies

Previous

The Results Are In! Research Participants Rate Their Experiences

Next

Coordination, Communication, and Operations Support (CCOS) is funded by theNational Center for Advancing Translational Sciences, National Institutes of Health.

HomeContact UsPrivacy PolicyAccessibility Statement
Freedom of Information (FOIA)Office of Inspector General (OIG)Cookie Preference
X-TwitterLinkedIn icon